Product Information
SULINDAC 150 MG TABLET is a generic product labeled by Actavis Pharma, Inc., priced at $0.1891 per EA under NDC 00591566105. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Apr 3, 1990. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
150 mg/1
Manufacturer
Actavis Pharma, Inc.NDC
00591566105
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
SULINDACApproval Type
Generic (ANDA)
FDA Application
ANDA071891FDA Approved
4/3/1990
TE Code
AB
On Market Since
4/3/1990
Pharmacological Classes
Price Statistics
The NADAC for SULINDAC 150 MG TABLET has been published 671 times since Nov 28, 2013, and over the history we have for it it has risen 50.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1891 per EA |
|---|---|
| All-time high | $0.1969 (Jun 10, 2026) |
| All-time low | $0.1256 (Nov 28, 2013) |
| 52-week high | $0.1969 |
| 52-week low | $0.1784 |
| Median price | $0.1560 |
| Average price | $0.1605 |
| Largest weekly change | -27.0% (Apr 17, 2024) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Actavis Pharma, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Sulindac market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nonsteroidal Anti-inflammatory Drug class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of SULINDAC 150 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for SULINDAC 150 MG TABLET, manufactured by Actavis Pharma, Inc., is $0.1891 per EA (NDC 00591566105), effective Sep 30, 2026.
How has the price of SULINDAC 150 MG TABLET changed over time?
Over the history we have for it, the NADAC for SULINDAC 150 MG TABLET has risen 50.5%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for SULINDAC 150 MG TABLET?
Since Nov 28, 2013, the NADAC for SULINDAC 150 MG TABLET has ranged from a low of $0.1256 (Nov 28, 2013) to a high of $0.1969 (Jun 10, 2026), with a median of $0.1560 per EA.
Are there cheaper alternatives to SULINDAC 150 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as SULINDAC 150 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures SULINDAC 150 MG TABLET?
SULINDAC 150 MG TABLET (NDC 00591566105) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.